Verrica Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:VRCA) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -16.06 M-12.68 M-10.04 M9.69 M-4.59 M -17.63 M Cash from investing activities 8 000—-11 K00 — Cash from financing activities 39.43 M-4.06 M-4.16 M-3.98 M13.64 M 1.45 M Free cash flow -16.06 M-12.68 M-10.04 M9.69 M-4.59 M -17.63 M

뉴스

Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript

베리카 파마슈티컬 주가, 파트너사의 일본 내 YCANTH 출시 후 상승

Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan

Verrica’s partner launches molluscum treatment in Japan

Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why

New Strong Buy Stocks for February 2nd

How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%

베리카 파마슈티컬스, TD Cowen ’매수’ 등급 재확인에 상승세

Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating

Verrica doses first patient in phase 3 trial for common wart treatment

베리카 파마슈티컬스, 이사회에 Charles Frantzreb 임명 및 주식 부여 승인

Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants